These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 8267907

  • 1. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J.
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [Abstract] [Full Text] [Related]

  • 2. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE.
    JAMA; 1993 Oct; 268(4):504-9. PubMed ID: 1619742
    [Abstract] [Full Text] [Related]

  • 3. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D.
    Arch Intern Med; 1996 Apr 22; 156(8):889-94. PubMed ID: 8774208
    [Abstract] [Full Text] [Related]

  • 4. Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand.
    Khongphatthanayothin M, Avihingsanon A, Teeratakulpisarn N, Phanuphak N, Buajoom R, Suwanmala P, Phanuphak P.
    AIDS Res Hum Retroviruses; 2012 Mar 22; 28(3):270-5. PubMed ID: 21899431
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary tuberculosis in HIV-infected patients with normal chest radiographs.
    Pedro-Botet J, Gutiérrez J, Miralles R, Coll J, Rubiés-Prat J.
    AIDS; 1992 Jan 22; 6(1):91-3. PubMed ID: 1543571
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
    Antonucci G, Girardi E, Raviglione MC, Ippolito G.
    JAMA; 1995 Jul 12; 274(2):143-8. PubMed ID: 7596002
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P, Rieder H, Bassetti S, Hirschel BJ, Ledergerber B, Malvy D.
    Schweiz Med Wochenschr; 1996 Nov 23; 126(47):2007-12. PubMed ID: 8984608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep 05; 46(RR-15):1-10. PubMed ID: 9332982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR, Brehm WT, Moore RD, Chaisson RE.
    Int J Tuberc Lung Dis; 1999 Mar 05; 3(3):248-54. PubMed ID: 10094327
    [Abstract] [Full Text] [Related]

  • 15. Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients.
    Rose DN, Schechter CB, Sacks HS.
    J Gen Intern Med; 1992 Mar 05; 7(6):589-94. PubMed ID: 1360493
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.
    Gourevitch MN, Hartel D, Selwyn PA, Schoenbaum EE, Klein RS.
    AIDS; 1999 Oct 22; 13(15):2069-74. PubMed ID: 10546859
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.
    Clin Infect Dis; 2003 Dec 15; 37(12):1686-92. PubMed ID: 14689352
    [Abstract] [Full Text] [Related]

  • 19. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
    Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, Machiels L, Steenbergen G, Pobee JO, Nunn P.
    Trans R Soc Trop Med Hyg; 1995 Dec 15; 89(1):78-82. PubMed ID: 7747316
    [Abstract] [Full Text] [Related]

  • 20. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Nyole S, Okwera A, Whalen CC, Nsubuga P, Pekovic V, Huebner R, Wallis RS, Mugyenyi PN, Mugerwa RD, Ellner JJ.
    Am J Respir Crit Care Med; 1998 Dec 15; 158(6):1790-6. PubMed ID: 9847269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.